BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 6044451)

  • 1. [Eosinophilic infiltrations of the lung as a radiologic manifestation of hypersensitivity to streptomycin, PAS and INH].
    Furman Z
    Gruzlica; 1967 Jan; 35(1):65-9. PubMed ID: 6044451
    [No Abstract]   [Full Text] [Related]  

  • 2. [The adverse effects of 2 therapy combinations (SM, PAS, INH, RMP, INH, EMB) in the intensive treatment phase of pulmonary tuberculosis].
    Knop P; Kindler U; Merholz T
    Med Welt; 1976 Feb; 27(8):389-90. PubMed ID: 1256308
    [No Abstract]   [Full Text] [Related]  

  • 3. [Severe hypersensitivity to SM, INH and PAS in a child with post-primary tuberculosis].
    Rykowska Z
    Gruzlica; 1969 Aug; 37(8):777-81. PubMed ID: 4242816
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of drug intolerance to antituberculosis chemotherapy.
    Neff TA; Coan BJ
    Dis Chest; 1969 Jul; 56(1):10-2. PubMed ID: 5789831
    [No Abstract]   [Full Text] [Related]  

  • 5. [Critical study of antibiotic tests systematically performed before treatment of pulmonary tuberculous patients].
    Benda R; Le Guillou F
    Sem Ther; 1965 Jan; 41(1):19-21. PubMed ID: 5879027
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anaphylactic shock caused by Fintozid].
    Földeş I; Norbert G
    Ftiziologia; 1971; 20(4):429-31. PubMed ID: 5162280
    [No Abstract]   [Full Text] [Related]  

  • 7. [The hemogram and ESR in pulmonary tuberculosis during intravenous administration of the primary antitubercular drugs].
    Koviazina AI; Utkin VV
    Probl Tuberk; 1971; 49(2):48-51. PubMed ID: 5561919
    [No Abstract]   [Full Text] [Related]  

  • 8. [Side effects of antibacterial drugs in the clinical course of pulmonary tuberculosis].
    Czkwianianc M; Markiewicz I
    Przegl Lek; 1969 Jun; 25(6):479-81. PubMed ID: 5805095
    [No Abstract]   [Full Text] [Related]  

  • 9. [Electroencephalographic changes and antitubercular treatments].
    Piéron R; Gautier H; Duhurt J; Kauffmann JP
    Sem Hop; 1972 Oct; 48(40):2585-91. PubMed ID: 4344846
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug intolerance and depressive states in tubercular patients].
    Scherding JP; Suerinck E
    Rev Tuberc Pneumol (Paris); 1967; 31(1):55-60. PubMed ID: 6037247
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rheumatic diseases caused by antitubercular drugs].
    Anastasatu C; Stoia I; Kaufman S; Ghenoiu O; Iancovici O
    Z Erkr Atmungsorgane Folia Bronchol; 1972 Jan; 136(1):51-63. PubMed ID: 4538033
    [No Abstract]   [Full Text] [Related]  

  • 13. [Frequency of side-effects of tuberulostatics and its relation to the applied combination].
    Bethge W
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):258-65. PubMed ID: 4302238
    [No Abstract]   [Full Text] [Related]  

  • 14. Case of extreme hypersensitivity to almost all antituberculous drugs.
    Agrawal R
    Br Med J; 1969 Nov; 4(5682):540. PubMed ID: 5354853
    [No Abstract]   [Full Text] [Related]  

  • 15. Duration of allergy to antituberculous drugs (PAS, SM and INH) in tuberculous patients.
    Brown H; Jennings TS; Coleman EO; Bulubash V
    Med Ann Dist Columbia; 1966 Dec; 35(12):652-7 passim. PubMed ID: 5231829
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of antitubercular agents on the fetus during therapy of tuberculous pregnant women].
    Ganguin G
    Z Erkr Atmungsorgane Folia Bronchol; 1971; 134(1):95-103. PubMed ID: 5209528
    [No Abstract]   [Full Text] [Related]  

  • 17. The predictability of hypersensitivity to anti-tuberculous drugs.
    Thompson JE
    Aust N Z J Med; 1973 Jun; 3(3):239-44. PubMed ID: 4517219
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of the immunological tests in the diagnosis of adverse effects of tuberculostatic therapy].
    Averbakh MM; Keleberda KIa; Gergert VIa; Mingazitinova DM
    Probl Tuberk; 1980 Mar; (3):27-30. PubMed ID: 6994091
    [No Abstract]   [Full Text] [Related]  

  • 19. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tuberculostatics. General adverse effects].
    Mordasini ER; Eulenberger J
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):499-518. PubMed ID: 4339952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.